We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Evaluating and Optimizing Critical Quality Attributes During Cell Line Development

Evaluating and Optimizing Critical Quality Attributes During Cell Line Development content piece image

Identifying and measuring critical quality attributes (CQAs) early in the cell line development (CLD) process is essential to ensuring product safety and efficacy. Failure to do this may result in drug attrition during late-stage clinical trials or issues with public safety once the product is on the market.


This listicle presents innovative tools that help optimize CQAs measurement during CLD to avoid late-stage setbacks.


Download this listicle to learn more about:

• Quantify protein titer

• Optimize glycosylation profiling

• Detect host-protein impurities



Brought to you by
Download the Listicle for FREE now!